Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Lipid Transporter MFSD2A in the Resolution of Colorectal Cancer-associated Inflammation: Implications for New Therapeutic Strategies

NCT06071598 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06071598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06071598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Lipid Transporter MFSD2A in the Resolution of Colorectal Cancer-associated Inflammation: Implications for New Therapeutic Strategies
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Unknown status
Start date
March 15, 2023
Completion date
March 15, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer